USD 0.04
(0.0%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 1.84 Million USD | -65.34% |
2022 | 5.31 Million USD | 696.8% |
2021 | -890.37 Thousand USD | -417.61% |
2020 | 280.33 Thousand USD | 0.0% |
2019 | - USD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | 419.86 Thousand USD | -15.39% |
2024 Q1 | 496.23 Thousand USD | -73.06% |
2023 Q3 | 1.52 Million USD | -67.51% |
2023 FY | 1.84 Million USD | -65.34% |
2023 Q4 | 1.84 Million USD | 20.51% |
2023 Q2 | 4.7 Million USD | 0.35% |
2023 Q1 | 4.68 Million USD | -11.78% |
2022 Q2 | 2.21 Million USD | 966.46% |
2022 Q1 | -255.98 Thousand USD | 71.25% |
2022 FY | 5.31 Million USD | 696.8% |
2022 Q4 | 5.31 Million USD | 424.85% |
2022 Q3 | -1.63 Million USD | -173.75% |
2021 FY | -890.37 Thousand USD | -417.61% |
2021 Q2 | -996.11 Thousand USD | -1074.08% |
2021 Q4 | -890.37 Thousand USD | 14.22% |
2021 Q3 | -1.03 Million USD | -4.2% |
2021 Q1 | 102.26 Thousand USD | -63.52% |
2020 Q4 | 280.33 Thousand USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2020 FY | 280.33 Thousand USD | 0.0% |
2019 FY | - USD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
BioQuest Corp. | 177.38 Thousand USD | -938.258% |
Clever Leaves Holdings Inc. | -4.81 Million USD | 138.258% |
Eagle Pharmaceuticals, Inc. | 7.14 Million USD | 74.224% |
Guardion Health Sciences, Inc. | -6.35 Million USD | 128.96% |
GSRX Industries Inc. | - USD | -Infinity% |
High Sierra Technologies, Inc. | 469.78 Thousand USD | -292.034% |
Instadose Pharma Corp. | - USD | -Infinity% |